Healthcare Global Enterprises – A Turnaround Story?
Moneylife Digital Team 29 July 2021
Healthcare Global Enterprises (HCG) is one of the largest providers of cancer care in India and the only specialised listed cancer care provider. Aggressive expansion in the past few years and regulatory challenges (cap on cancer drug margins), followed by the pandemic, hit the financials of the company leading to lower margins, lower returns and high debt. However, private equity firm CVC...
Premium Content
This is a premium article. Your annual or monthly subscription will not give you access if it is outside your subscription period. You can buy it individually
Pay Per Article Gift An Article
Subscriptions
Access will cover your subscription period. Archives not included. Articles outside the subscription period can be bought individually.
Yearly Digital Access Monthly Digital Access
Already a subscriber ? Log in
IPO Review: Glenmark Life Sciences Ltd
Moneylife Digital Team 28 July 2021
Glenmark Life Sciences Ltd (GLSL) is a developer and manufacturer of active pharmaceutical ingredients (APIs) in chronic therapeutic areas, including cardiovascular disease (CVS), central nervous system disease (CNS), pain...
Max Ventures: A Special Situations Opportunity?
Moneylife Digital Team 27 July 2021
Max Ventures and Industries Ltd (MVIL) operates across two primary business verticals of real estate and specialty packaging films through its subsidiary companies: Max Estates Ltd, Max Asset Services Ltd, Max I Ltd and Max...
Jubilant Pharmova: Strong Showing in June Quarter
Moneylife Digital Team 27 July 2021
Jubilant Pharmova Ltd (JPL) delivered a growth of 3% q-o-q (quarter-on-quarter) in revenue in Q1FY21-22 due to gradual recovery in all segments. Operating profit remained flat q-o-q at Rs375 crore with operating margins at 23%, as...
Free Helpline
Legal Credit
Feedback